Caris Life Sciences, Inc.
Nasdaq · Services-Medical Laboratories
Company Overview
A concise company profile alongside the latest public filing activity.
Caris Life Sciences is a molecular science and technology company that provides comprehensive genomic and molecular profiling of tumors to help physicians guide cancer treatment decisions, using next-generation sequencing and AI-driven analysis to match patients with therapies.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Denton John RusselSee Remarks | Sell | $239K | 7,500at $31.82 | Sep 22, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable CAI activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.